Discover 1,711 paid clinical trials in Bloomfield Hills, Michigan. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,711
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
for
Acral Lentiginous Melanoma,
Location: Brighton MI, Ann Arbor MI, Toledo OH, Perrysburg OH,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT04511013
Phase 2, Recruiting
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
for
Cutaneous Melanoma, Stage II
Location: Brighton MI, Ann Arbor MI, Avon OH, Westlake OH,
Sponsor: Melanoma and Skin Cancer Trials Limited
Sex: All
Age: 18+
Code: NCT03860883
Recruiting
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
for
Metastatic Clear Cell Renal Cell Carcinoma,
Location: Brighton MI, Ann Arbor MI, Avon OH, Battle Creek MI,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT04510597
Phase 3, Recruiting
A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma Gangrenosum
for
Pyoderma Gangrenosum
Location: Ann Arbor MI, Flint MI, Cleveland OH, Columbus OH,
Sponsor: LEO Pharma
Sex: All
Age: 18+
Code: NCT06624670
Phase 3, Recruiting
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
for
Pediatric Migraine
Location: Ann Arbor MI, Cleveland OH, Grand Rapids MI, Amherst NY,
Sponsor: Pfizer
Sex: All
Age: 6 - 17
Code: NCT04649242
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
for
Astrocytoma, IDH-Mutant, Grade 3
Location: Brighton MI, Ann Arbor MI, Grand Rapids MI, Wyoming MI,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 12+
Code: NCT07215910
Phase 3, Recruiting
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)